Literature DB >> 26261336

Swift antibodies to counter emerging viruses.

Dennis R Burton1, Erica Ollmann Saphire2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26261336      PMCID： PMC4547222          DOI： 10.1073/pnas.1513050112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

Review 2.  The therapeutic monoclonal antibody market.

Authors:  Dawn M Ecker; Susan Dana Jones; Howard L Levine
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Authors:  Tianlei Ying; Lanying Du; Tina W Ju; Ponraj Prabakaran; Candy C Y Lau; Lu Lu; Qi Liu; Lili Wang; Yang Feng; Yanping Wang; Bo-Jian Zheng; Kwok-Yung Yuen; Shibo Jiang; Dimiter S Dimitrov
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

4.  Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.

Authors:  Liwei Jiang; Nianshuang Wang; Teng Zuo; Xuanling Shi; Kwok-Man Vincent Poon; Yongkang Wu; Fei Gao; Danyang Li; Ruoke Wang; Jianying Guo; Lili Fu; Kwok-Yung Yuen; Bo-Jian Zheng; Xinquan Wang; Linqi Zhang
Journal:  Sci Transl Med       Date:  2014-04-28       Impact factor: 17.956

5.  Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.

Authors:  Xian-Chun Tang; Sudhakar S Agnihothram; Yongjun Jiao; Jeremy Stanhope; Rachel L Graham; Eric C Peterson; Yuval Avnir; Aimee St Clair Tallarico; Jared Sheehan; Quan Zhu; Ralph S Baric; Wayne A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

6.  Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

Authors:  A Bermingham; M A Chand; C S Brown; E Aarons; C Tong; C Langrish; K Hoschler; K Brown; M Galiano; R Myers; R G Pebody; H K Green; N L Boddington; R Gopal; N Price; W Newsholme; C Drosten; R A Fouchier; M Zambon
Journal:  Euro Surveill       Date:  2012-10-04

Review 7.  Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases.

Authors:  R M Chanock; J E Crowe; B R Murphy; D R Burton
Journal:  Infect Agents Dis       Date:  1993-06

Review 8.  Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.

Authors:  L Zeitlin; R A Cone; K J Whaley
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

9.  Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa.

Authors:  Miles W Carroll; David A Matthews; Julian A Hiscox; Michael J Elmore; Georgios Pollakis; Andrew Rambaut; Roger Hewson; Isabel García-Dorival; Joseph Akoi Bore; Raymond Koundouno; Saïd Abdellati; Babak Afrough; John Aiyepada; Patience Akhilomen; Danny Asogun; Barry Atkinson; Marlis Badusche; Amadou Bah; Simon Bate; Jan Baumann; Dirk Becker; Beate Becker-Ziaja; Anne Bocquin; Benny Borremans; Andrew Bosworth; Jan Peter Boettcher; Angela Cannas; Fabrizio Carletti; Concetta Castilletti; Simon Clark; Francesca Colavita; Sandra Diederich; Adomeh Donatus; Sophie Duraffour; Deborah Ehichioya; Heinz Ellerbrok; Maria Dolores Fernandez-Garcia; Alexandra Fizet; Erna Fleischmann; Sophie Gryseels; Antje Hermelink; Julia Hinzmann; Ute Hopf-Guevara; Yemisi Ighodalo; Lisa Jameson; Anne Kelterbaum; Zoltan Kis; Stefan Kloth; Claudia Kohl; Miša Korva; Annette Kraus; Eeva Kuisma; Andreas Kurth; Britta Liedigk; Christopher H Logue; Anja Lüdtke; Piet Maes; James McCowen; Stéphane Mély; Marc Mertens; Silvia Meschi; Benjamin Meyer; Janine Michel; Peter Molkenthin; César Muñoz-Fontela; Doreen Muth; Edmund N C Newman; Didier Ngabo; Lisa Oestereich; Jennifer Okosun; Thomas Olokor; Racheal Omiunu; Emmanuel Omomoh; Elisa Pallasch; Bernadett Pályi; Jasmine Portmann; Thomas Pottage; Catherine Pratt; Simone Priesnitz; Serena Quartu; Julie Rappe; Johanna Repits; Martin Richter; Martin Rudolf; Andreas Sachse; Kristina Maria Schmidt; Gordian Schudt; Thomas Strecker; Ruth Thom; Stephen Thomas; Ekaete Tobin; Howard Tolley; Jochen Trautner; Tine Vermoesen; Inês Vitoriano; Matthias Wagner; Svenja Wolff; Constanze Yue; Maria Rosaria Capobianchi; Birte Kretschmer; Yper Hall; John G Kenny; Natasha Y Rickett; Gytis Dudas; Cordelia E M Coltart; Romy Kerber; Damien Steer; Callum Wright; Francis Senyah; Sakoba Keita; Patrick Drury; Boubacar Diallo; Hilde de Clerck; Michel Van Herp; Armand Sprecher; Alexis Traore; Mandiou Diakite; Mandy Kader Konde; Lamine Koivogui; N'Faly Magassouba; Tatjana Avšič-Županc; Andreas Nitsche; Marc Strasser; Giuseppe Ippolito; Stephan Becker; Kilian Stoecker; Martin Gabriel; Hervé Raoul; Antonino Di Caro; Roman Wölfel; Pierre Formenty; Stephan Günther
Journal:  Nature       Date:  2015-06-17       Impact factor: 49.962

Review 10.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226
View more
  4 in total

1.  The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.

Authors:  Liam B King; Marnie L Fusco; Andrew I Flyak; Philipp A Ilinykh; Kai Huang; Bronwyn Gunn; Robert N Kirchdoerfer; Kathryn M Hastie; Amandeep K Sangha; Jens Meiler; Galit Alter; Alexander Bukreyev; James E Crowe; Erica Ollmann Saphire
Journal:  Cell Host Microbe       Date:  2018-01-10       Impact factor: 21.023

Review 2.  Antibody-mediated protection against Ebola virus.

Authors:  Erica Ollmann Saphire; Sharon L Schendel; Bronwyn M Gunn; Jacob C Milligan; Galit Alter
Journal:  Nat Immunol       Date:  2018-10-17       Impact factor: 25.606

Review 3.  Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome.

Authors:  Davide Corti; Nadia Passini; Antonio Lanzavecchia; Maria Zambon
Journal:  J Infect Public Health       Date:  2016-04-19       Impact factor: 3.718

4.  Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.

Authors:  Elizabeth M Parzych; Sunita Gulati; Bo Zheng; Mamadou A Bah; Sarah T C Elliott; Jacqueline D Chu; Nancy Nowak; George W Reed; Frank J Beurskens; Janine Schuurman; Peter A Rice; David B Weiner; Sanjay Ram
Journal:  mBio       Date:  2021-03-16       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.